Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: BIOCRYST PHARMACEUTICALS INC
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2024-09-09 to 2025-09-08
Current total value of award: $374625.81
Description: BEROTRALSTAT HCL 150MG CAP,ORAL TRADE NAME: ORLADEYO 150MG CAP